chevron_leftBack
As of 24 April 2025, RxSight, Inc. has a market cap of $585.9M USD, ranking #10994 globally and #2185 in the United States. It ranks #1074 in the Healthcare sector, and #115 in the Medical Devices industry.
Key Stats
Market Cap
$585.9MUSD
Enterprise Value
$360.97MUSD
Revenue (TTM)
$139.93MUSD
EBITDA (TTM)
-$33.28MUSD
Net Income (TTM)
-$27.46MUSD
EBITDA Margin
-24%
Profit Margin
-20%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Ronald Kurtz
open_in_new
Employees
498
Founded
1997
IPO
30 Jul 2021
Website
rxsight.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.1% | -0.3% | -42% | -55% | -71% | -72% |
Upcoming Earnings
Earnings Date
Wed, May 7
Earnings Time
bedtime
After Close
EPS Estimate
-$0.0600
Revenue Estimate
$37.89M
28% yoy
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
RXST
RxSight Inc
ISIN: US78349D1072
Shares Out.:
Shares Outstanding:
40.62M1
Shares Float:
38.5M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
14.47 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About RxSight, Inc.
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
